For the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.
On Friday, the US Food and Drug Administration authorized a new monoclonal antibody therapy that appears to work against the omicron variant of COVID-19.
Bebtelovimab, made by Eli Lilly, is authorized for use in patients 12…